Dominique Louis Nestor Ghislain Surleraux
41Patents
9h-index
47Co-inventors
71Inventor score
Filing activity: Apr 3, 1998 → Mar 9, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7622582B2 | Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one | Chemistry; Metallurgy | 41 | Expired |
| US8022077B2 | Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof | Human Necessities | 29 | Expired |
| US8030318B2 | Fused bicyclic inhibitors of HCV | Human Necessities | 28 | Expired |
| US6197772A | 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives | Emerging Cross-Sectional Technologies | 17 | Expired |
| US6521621B1 | 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives | Emerging Cross-Sectional Technologies | 17 | Expired |
| USRE37886E1 | 1-(1,2-Disubstituted piperidinyl)-4-substituted piperazine derivatives | General | 16 | Expired |
| US6169097A | 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives | Chemistry; Metallurgy | 15 | Expired |
| US8349869B2 | Macrocylic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 12 | Active |
| US7989471B2 | Macrocyclic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 9 | Active |
| US7977342B2 | HCV inhibiting bi-cyclic pyrimidines | Emerging Cross-Sectional Technologies | 8 | Active |
| US6110939A | (Benzimidazolyl- and imidazopyridinyl) containing 1-(1,2-disubstituted piperidinyl) derivatives | Chemistry; Metallurgy | 8 | Expired |
| US8012939B2 | Macrocyclic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 7 | Active |
| US7465727B2 | (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5-c][1,3]Benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors | Human Necessities | 3 | Expired |
| US7126015B2 | Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6218381A | Fused imidazole derivatives as multidrug resistance modulators | Chemistry; Metallurgy | 2 | Expired |
| US9290502B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US7244752B2 | Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US7745432B2 | (1,10b-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5 C][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors | Human Necessities | 1 | Active |
| US8741926B2 | Macrocyclic inhibitors of hepatitis C virus | Emerging Cross-Sectional Technologies | 1 | Active |
| US6346540B1 | 1-(1,2-disubstituted pipeidinyl)-4-substituted piperidine derivatives | Chemistry; Metallurgy | 1 | Expired |
| US8227407B2 | Macrocyclic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 1 | Active |
| US8754116B2 | Macrocyclic inhibitors of hepatitis C virus | Chemistry; Metallurgy | 0 | Active |
| US8143421B2 | Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9708328B2 | Pteridines useful as HCV inhibitors and methods for the preparation thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8084494B2 | Substituted aminophenylsulfonamide compounds as HIV protease inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.